TCL Archive In Brief: Most NCI Grants, Including Noncompeting And r01s, Will Take Cuts Of At Least 4 Percent; Paylines Set January 22, 1982
Primary Source Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia May 6, 2021
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014